Search hospitals > Ontario > LONDON
London Regional Cancer Program
Claim this profileLONDON, Ontario N6A 4L6
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
412 reported clinical trials
22 medical researchers
Summary
London Regional Cancer Program is a medical facility located in LONDON, Ontario. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. London Regional Cancer Program is involved with conducting 412 clinical trials across 275 conditions. There are 22 research doctors associated with this hospital, such as David Palma, MD, Lucas Mendez, MD, Francisco E. Perera, and Michael Lock, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
David Palma, MDLondon Health Sciences Centre5 years of reported clinical research
Studies Cancer
Studies Head and Neck Cancers
10 reported clinical trials
14 drugs studied
Lucas Mendez, MDLondon Regional Cancer Program1 year of reported clinical research
Studies Prostate Cancer
Studies Endometrial Cancer
7 reported clinical trials
14 drugs studied
Francisco E. PereraLondon Regional Cancer Program1 year of reported clinical research
Studies Breast Cancer
Studies Radiotherapy
3 reported clinical trials
4 drugs studied
Michael Lock, MDLondon Health Sciences Centre, London Regional Cancer Program5 years of reported clinical research
Studies Cancer
Studies Hepatocellular Carcinoma
3 reported clinical trials
7 drugs studied
Clinical Trials running at London Regional Cancer Program
Breast Cancer
Prostate Cancer
Cancer
Brain Tumor
Non-Small Cell Lung Cancer
Meningioma
Tumors
Oral Squamous Cell Carcinoma
Head and Neck Cancers
Squamous Cell Carcinoma
Hypofractionated Radiotherapy
for Breast Cancer
This study is evaluating whether a shorter course of radiation therapy is as effective as a longer course of radiation therapy.
Recruiting2 awards Phase 33 criteria
Imlunestrant
for Early Breast Cancer
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Recruiting2 awards Phase 36 criteria
Omitting Radiation Therapy
for Breast Cancer
This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at London Regional Cancer Program?
London Regional Cancer Program is a medical facility located in LONDON, Ontario. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. London Regional Cancer Program is involved with conducting 412 clinical trials across 275 conditions. There are 22 research doctors associated with this hospital, such as David Palma, MD, Lucas Mendez, MD, Francisco E. Perera, and Michael Lock, MD.
Where is London Regional Cancer Program located?
The London Regional Cancer Program hospital is situated at 800 Commissioners Rd E, London, Ontario, Canada. For parking, visitors are advised to use lots P1 and P2 across from the main entrance on Level 2. Handicapped parking is available in lot P2.
Who should I call to ask about financial aid or insurance network?
For financial assistance related to cancer treatment, CancerCare's Hopeline at 800-813-4673 offers support for transportation, home care, child care, pet assistance, and wellness programs. The London Regional Cancer Program provides two patient assistance funds: the Massel-Cruickshank Breast Cancer Patient Assistance Fund and the Gene Goodreau Patient Assistance Fund, for emergency, short-term financial support. Additional resources and information can be found by contacting the London Regional Cancer Program at 519.685.8742.
What insurance does London Regional Cancer Program accept?
The London Regional Cancer Program (LRCP) at London Health Sciences Centre (LHSC) accepts insurance plans for cancer care services in Ontario, Canada, including the Ontario Health Insurance Plan (OHIP). OHIP covers most services provided by the LRCP, including radiation therapy, chemotherapy, and supportive care. For details on the acceptance of specific private insurance plans, please contact the LRCP directly.
What awards or recognition has London Regional Cancer Program received?
The London Regional Cancer Program (LRCP) at London Health Sciences Centre is renowned for its exceptional research and care, highlighted by Dr. David Palma's Canadian Cancer Society Award for Excellence. It houses the Cancer Clinical Research Unit (CCRU), facilitating and supporting clinical and translational research. Annually, the CCRU recruits 250-400 patients for 50 to 70 active trials, emphasizing its commitment to advancing cancer treatment.